期刊文献+

帕罗西汀单用与帕罗西汀合并喹硫平对强迫症疗效的对照研究 被引量:3

A comparative study of paroxetine combining with quetiapine in the treatment of obsessive-compulsive disorder
下载PDF
导出
摘要 目的探讨帕罗西汀合并喹硫平治疗强迫症的疗效。方法50例强迫症患者随机分为帕罗西汀组和帕罗西汀合并喹硫平组,疗程8周。采用强迫症量表(Y-BOCS),汉密尔顿焦虑量表(HAMA),汉密尔顿抑郁量表(HAMD),评定疗效。结果治疗结束时两组Y-BOCS,HAMA,HAMD的评分均显著下降,而合并喹硫平组更明显。结论帕罗西汀合并喹硫平治疗强迫症可以提高疗效。 Objective To investigate the efficacy of paroxetine combining with quetiapine in the treatment of obsessive-compulsive disorder(OCD). Methods A total of 50 patients with OCD were randomly treated with paroxetine only or paroxetine combining with quetiapine . The efficacy was measured with Yale-Brown obsessive compulsive scale(Y-BOCS), Hamilton anxiety scale(HAMA) and Hamilton depression scale (HAMD). Results There were significant differences between two groups in the reducing rate of Y-BOCS, HAMA and HAMD. Conclusion It is suggested that paroxetine combining with quetiapine could improve efficacy in the treatment of OCD.
出处 《精神医学杂志》 2007年第5期289-290,共2页 Journal of Psychiatry
关键词 帕罗西汀 喹硫平 强迫症 Paroxetine Quetiapine Obsessive-compulsive disorder
  • 相关文献

参考文献4

  • 1张华,刘严.帕罗西汀合并利培酮治疗强迫症临床观察[J].临床精神医学杂志,2005,15(1):5-5. 被引量:5
  • 2[2]McDougle CJ,Epperson CN,Pelton GH,et al.A double-blind placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refrefractory obsessive-compulsive disorder[J].Arch Gen Psychiatry,2000,57 (8):794 ~801
  • 3[3]Ravizza L,Barzega G,Bogetto F,et al.Therapelltic effect and safety of adjunctive risperidone in refractoy obsessivecompulsive disorder[J].Psychopharmacol Bull,1996,32(4):677~682
  • 4喻东山.强迫症的机制与治疗.临床精神医学杂志,2000,10(2):128-128.

二级参考文献2

  • 1Mahendran R. Obsessional symptoms associated with risperidone treatment[J]. Aust N J Psychiatry, 1998,32:299.
  • 2Mendelowita AJ,Lieberman JA.New findings in the use of atypical antipsychotic drugs[ J]. J Clin Psychiatry, 1995,2: 3-12.

共引文献44

同被引文献56

  • 1张丽霞,杨彦春.强迫症患者认知功能特点的研究[J].中华精神科杂志,2005,38(1):23-26. 被引量:18
  • 2李刚,陈清刚,张秋红,李涛.奎硫平与利培酮对精神分裂症患者认知功能的影响[J].中国行为医学科学,2005,14(11):1007-1008. 被引量:16
  • 3王玉,刘盈,汤艳清.阿立哌唑作为增效剂治疗难治性强迫症的临床观察[J].中国行为医学科学,2006,15(9):800-801. 被引量:9
  • 4胡忠心,曹天忠.帕罗西汀治疗强迫障碍疗效分析[J].临床心身疾病杂志,2007,13(3):202-202. 被引量:3
  • 5Pallanti S, Hollander E, Bienstock C, et al. Treatment non-response in OCD : methodological issues and operational definitions. Int J Neuropsychopharmacol, 2002, 5 : 181-191.
  • 6Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive-compulsive disorder. Int J Neuropsychopharmacol,2005,8 : 107-129.
  • 7Keefe RS, Silva SG, Perkins DO, et al. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull, 1999,25:201-222.
  • 8Ichikawa J,Li Z, Dai J, et al. Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HTlA receptor agonism. Brain Res, 2002,956:349-357.
  • 9Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol,2002,67:53-83.
  • 10Li X, May RS, Tolbert LC, et al. Risperidone and halopefidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study. J Clin Psychiatry,2005,66:736-743.

引证文献3

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部